BlackRock’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
VCM
ZDA
NAMA
BlackRock's WGS Position: Q1 2026 in Review
BlackRock reduced its GeneDx Holdings (WGS) stake by 0.6% in Q1 2026, selling an estimated $856K and leaving 1,550,708 shares worth $99.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2111.
BlackRock first reported a position in WGS in Q2 2021 and has held it in 20 quarters since. The position peaked at $203M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.
- BlackRock held 1,550,708 shares of GeneDx Holdings worth $99.6M as of Q1 2026.
- BlackRock sold 9,386 GeneDx Holdings shares in Q1 2026, an estimated $856K.
- GeneDx Holdings made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2111 holding.
- BlackRock first reported a position in GeneDx Holdings in Q2 2021 and has held it in 20 quarters since.
- BlackRock's GeneDx Holdings position peaked at $203M in Q4 2025.
- 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.